These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15526592)
1. [Transdermal drug delivery systems]. Foco A; Hadziabdić J; Becić F Med Arh; 2004; 58(4):230-4. PubMed ID: 15526592 [TBL] [Abstract][Full Text] [Related]
2. [Transdermal therapeutic systems for drug administration]. Hupfeld S; Gravem H Tidsskr Nor Laegeforen; 2009 Mar; 129(6):532-3. PubMed ID: 19282891 [TBL] [Abstract][Full Text] [Related]
3. Bioadhesive film for dermal and transdermal drug delivery. Padula C; Nicoli S; Aversa V; Colombo P; Falson F; Pirot F; Santi P Eur J Dermatol; 2007; 17(4):309-12. PubMed ID: 17540637 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle delivery for transdermal HRT. Valenzuela P; Simon JA Maturitas; 2012 Sep; 73(1):74-80. PubMed ID: 22325243 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle delivery for transdermal HRT. Valenzuela P; Simon JA Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909 [TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. Henzl MR; Loomba PK J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327 [TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of contraceptives. Friend DR Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099 [TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers. Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596 [TBL] [Abstract][Full Text] [Related]
10. A commentary on transdermal drug delivery systems in clinical trials. Watkinson AC J Pharm Sci; 2013 Sep; 102(9):3082-8. PubMed ID: 23468246 [TBL] [Abstract][Full Text] [Related]
11. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148 [TBL] [Abstract][Full Text] [Related]
12. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends. Perumal O; Murthy SN; Kalia YN Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120 [TBL] [Abstract][Full Text] [Related]
13. On the characterization of medicated plasters containing NSAIDs according to novel indications of USP and EMA: adhesive property and in vitro skin permeation studies. Cilurzo F; Gennari CG; Selmin F; Franzé S; Musazzi UM; Minghetti P Drug Dev Ind Pharm; 2015 Feb; 41(2):183-9. PubMed ID: 24164486 [TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations. Pfister WR; Hsieh DS Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149 [TBL] [Abstract][Full Text] [Related]
15. Release liner removal method for transdermal drug delivery systems (TDDS). Wokovich AM; Shen M; Doub WH; Machado SG; Buhse LF J Pharm Sci; 2010 Jul; 99(7):3177-87. PubMed ID: 20135693 [TBL] [Abstract][Full Text] [Related]
16. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration. Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249 [TBL] [Abstract][Full Text] [Related]
17. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Ahmed TA; El-Say KM Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393 [TBL] [Abstract][Full Text] [Related]
18. [Studies on transdermal delivery system of isosorbide dinitrate]. Ji AM; Jiang XT; Wang XF; Zou HQ Yao Xue Xue Bao; 1992; 27(11):858-63. PubMed ID: 1300032 [TBL] [Abstract][Full Text] [Related]
19. [Transdermal therapeutic methods]. Aiache JM Ann Cardiol Angeiol (Paris); 1997; 46(7):441-9. PubMed ID: 9452779 [TBL] [Abstract][Full Text] [Related]
20. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]